Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by American Thoracic Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Thoracic Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Itch - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

38:59
 
Share
 

Manage episode 517684901 series 2625214
Content provided by American Thoracic Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Thoracic Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This episode was created in collaboration with, and first posted on, The Itch podcast.

Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.

In this episode, The Itch breaks down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published Oct. 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”

Read the paper: https://www.atsjournals.org/doi/abs/10.1164/rccm.202410-1894OC

  continue reading

472 episodes

Artwork
iconShare
 
Manage episode 517684901 series 2625214
Content provided by American Thoracic Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Thoracic Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This episode was created in collaboration with, and first posted on, The Itch podcast.

Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.

In this episode, The Itch breaks down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published Oct. 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”

Read the paper: https://www.atsjournals.org/doi/abs/10.1164/rccm.202410-1894OC

  continue reading

472 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play